Page last updated: 2024-09-03

morphiceptin, n-me-phe(3)- and tyrosyl-prolyl-leucyl-glycinamide

morphiceptin, n-me-phe(3)- has been researched along with tyrosyl-prolyl-leucyl-glycinamide in 1 studies

Compound Research Comparison

Studies
(morphiceptin, n-me-phe(3)-)
Trials
(morphiceptin, n-me-phe(3)-)
Recent Studies (post-2010)
(morphiceptin, n-me-phe(3)-)
Studies
(tyrosyl-prolyl-leucyl-glycinamide)
Trials
(tyrosyl-prolyl-leucyl-glycinamide)
Recent Studies (post-2010) (tyrosyl-prolyl-leucyl-glycinamide)
951110900

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ge, LJ; Hackler, L; Kastin, AJ; Zadina, JE1

Other Studies

1 other study(ies) available for morphiceptin, n-me-phe(3)- and tyrosyl-prolyl-leucyl-glycinamide

ArticleYear
Mu, delta, and kappa opiate receptor binding of Tyr-MIF-1 and of Tyr-W-MIF-1, its active fragments, and two potent analogs.
    Life sciences, 1994, Volume: 55, Issue:24

    Topics: Amino Acid Sequence; Animals; Brain; Cerebellum; Endorphins; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Guinea Pigs; Molecular Sequence Data; MSH Release-Inhibiting Hormone; Peptide Fragments; Peptides, Cyclic; Rats; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Structure-Activity Relationship; Synaptic Membranes

1994